Abstract B04: Development and comparison of 12-week and 4-week dietary interventions among Hispanic breast cancer survivors
A. Corina Aycinena(Columbia University Irving Medical Center), Parisa Tehranifar(Columbia University), Mary Beth Terry(Columbia University Irving Medical Center), Isobel R. Contento(Columbia University), Katherine D. Crew, Heather Greenlee(Fred Hutch Cancer Center), Dawn L. Hershman(Columbia University), John F. Richardson(Imperial College London), Pam Koch(Columbia University), Ann Ogden Gaffney(Your Community Foundation)
Cited by 0
Related Papers
Epidemiology of gastric cancer
|World Journal of Gastroenterology|2006|2.1k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991
Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment
|CA A Cancer Journal for Clinicians|2017|762